News

Article

Pharmaceutical Technology

Pharmaceutical Technology-08-01-2001
Volume2001 Supplement
Issue 2

Third-Party Technology Transfer

Author(s):

David G. Sixsmith

Careful planning and decision-making can circumvent possible delays in technology transfers.

External Link - article-5232.pdf

Articles in this issue
Creating a Successful Partnership with a Contract Manufacturer
Outsourcing Outlook
Creative Solutions in Client-CRO Relationships
Third-Party Technology Transfer
The Squeeze in Contract Manufacturing
Preparing Requests for Quotations for Commercial Pharmaceutical Manufacturing

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Related Content
Blockchain for transparent supply chain tracking | Image Credit: ©Andrey -stock.adobe.com
September 4th 2025

Keys to Navigating the Complex Drug Supply Chain

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
September 4th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
South San Francisco, CA, USA - Mar 1, 2020: American clinical-stage biopharmaceutical company Cytokinetics, Inc.'s Headquarters in South San Francisco, California. | Image Credit: © Tada Images - stock.adobe.com
September 4th 2025

Aficamten Bests Metoprolol in Cytokinetics' Trial for Obstructive Hypertrophic Cardiomyopathy

Patrick Lavery
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
September 4th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Shanghai.China-Jan. 8th 2022: Fosun Pharma company logo on office building at night. A Chinese pharmaceutical company mostly owned by Fosun International | Image Credit: © Robert - stock.adobe.com
September 4th 2025

Fosun Pharma to Exclusively Develop Accro Bioscience Anti-Inflammatory in China

Patrick Lavery
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
September 4th 2025

Mislabeling Leads to Cyclobenzaprine Hydrochloride Recall

Susan Haigney
© 2025 MJH Life Sciences

All rights reserved.